Skip to content

Subtypes & Genetics: Classic vs. ADOA-Plus

Last updated:

Autosomal Dominant Optic Atrophy (ADOA) usually causes isolated vision loss, known as Classic ADOA. However, up to 29% of patients develop ADOA-Plus, which involves extra symptoms like hearing loss, muscle weakness, and balance issues caused by specific OPA1 gene mutations.

Key Takeaways

  • Classic ADOA primarily causes isolated vision loss, while ADOA-Plus can affect hearing, muscle strength, and coordination.
  • Because ADOA is an autosomal dominant condition, an individual with the mutation has a 50% chance of passing it to each child.
  • Hearing loss is the most common extra-ocular symptom in ADOA-Plus, making baseline hearing tests an important part of care.
  • Specific genetic mutations, such as missense mutations or those in exons 14, 15, and 17, make the ADOA-Plus subtype more likely.
  • Females may experience more significant vision changes during adolescence due to hormonal influences on mitochondrial health.

While most cases of Autosomal Dominant Optic Atrophy (ADOA) primarily affect the eyes, the genetic mutation responsible for the condition can sometimes influence other systems in the body. Understanding the genetics and whether you or your child has the “Classic” or “Plus” form helps your medical team provide more comprehensive care.

Understanding “Autosomal Dominant” Genetics

The name of the disease itself explains how it is passed through families. Autosomal Dominant means that a person only needs to inherit one copy of the mutated gene (from either parent) to develop the condition [1][2].

  • The 50% Rule: Because of this dominant inheritance pattern, an individual with ADOA has a 50% chance of passing the mutation on to each of their children [1]. This is a critical piece of information for family planning and helps explain why the condition often appears across multiple generations.

Classic ADOA: Isolated Vision Loss

The majority of individuals with an OPA1 mutation have Classic ADOA. In this form, the symptoms are isolated to the optic nerve, resulting in the gradual vision and color changes discussed in previous sections [3][4].

  • Genetic Link: This presentation is most commonly associated with mutations in exons 8 and 9 of the OPA1 gene [3].
  • Stability: Classic ADOA typically follows a slow, predictable course and does not involve other organs [5].

ADOA-Plus: A Broader Spectrum

Approximately 20% to 29% of individuals with OPA1 mutations develop ADOA-Plus (also known as DOA+) [3][4]. In these cases, the “power plant” failure in the mitochondria affects more than just the retinal ganglion cells.

Extra-Ocular Symptoms to Watch For:

  • Hearing Loss (Hypoacusis): This is the most common “plus” symptom. It often presents as auditory neuropathy, where the ear hears sound but the nerve has trouble sending that sound to the brain [4][6]. It typically begins 3 to 13 years after the initial vision symptoms [6].
  • Balance and Coordination (Ataxia): Some patients may experience mild shakiness or difficulty with precise movements [4][7].
  • Muscle Issues (Myopathy): This can manifest as weakness in the muscles closest to the center of the body (proximal myopathy) or limited eye movement (ophthalmoplegia) [4][7].
  • Nerve Tingling (Neuropathy): A small number of patients report tingling or weakness in the hands and feet [4][7].

Why Does the “Plus” Form Happen?

Researchers have identified specific patterns that make the “plus” phenotype more likely:

  • Mutation Location: Mutations in exons 14, 15, and 17 are more strongly linked to ADOA-Plus [3].
  • Mutation Type: Missense mutations (where a single “letter” in the genetic code is swapped) are highly associated with ADOA-Plus compared to other types of mutations [6][8].

Factors Influencing Severity

The way ADOA shows up (expressivity) can be influenced by several factors:

  • Gender and Puberty: Research suggests that some females may experience more significant vision loss or nerve thinning during adolescence [9]. This may be due to how sex hormones like estrogen and their precursors interact with mitochondrial health [9]. While this can sound alarming to parents of girls, knowing this allows doctors to closely monitor vision during these years so that low-vision aids can be adjusted if necessary.
  • Birth Factors: Early data suggests that gestational age and birth weight may play a role in how severe the vision loss becomes later in life, with longer gestation periods correlating with better visual sensitivity [10].

Knowing these subtypes isn’t about increasing fear—it’s about early detection. If a “plus” symptom is identified early, such as hearing loss, it can be managed with specialized tools (like cochlear implants or hearing aids) to ensure the best possible quality of life [11].

Frequently Asked Questions

What is the difference between Classic ADOA and ADOA-Plus?
Classic ADOA primarily causes gradual vision loss isolated to the optic nerve. ADOA-Plus affects other parts of the body as well, potentially causing hearing loss, balance issues, or muscle weakness.
What is my chance of passing ADOA to my children?
Because ADOA is an autosomal dominant condition, a person with the OPA1 gene mutation has a 50% chance of passing it on to each of their children. This inheritance pattern explains why the condition often appears across multiple generations in a family.
What are the symptoms of ADOA-Plus?
The most common symptom of ADOA-Plus is hearing loss, which typically begins years after initial vision changes. Other symptoms can include poor coordination, muscle weakness, and tingling in the hands and feet.
Should I get a hearing test if I have ADOA?
Yes, a baseline hearing test is recommended for individuals with ADOA, especially since hearing loss is the most common extra-ocular symptom in the ADOA-Plus subtype. Early detection allows for effective management with hearing aids or cochlear implants.
Does puberty affect ADOA vision loss?
Some research suggests that females may experience more significant vision changes during adolescence. This is believed to be related to how sex hormones interact with mitochondrial health, making close monitoring by an eye doctor important during these years.

Questions for Your Doctor

  • Does my (or my child's) genetic report show a missense mutation or a mutation in exons 14, 15, or 17?
  • Given the autosomal dominant inheritance, should we pursue genetic testing for siblings or other family members?
  • Should we schedule a baseline hearing test (audiogram) to monitor for auditory neuropathy?
  • Is there a neurologist on the care team who can help evaluate for coordination (ataxia) or muscle issues?
  • Given the 'plus' possibility, are there specific neurological signs—like changes in gait or balance—that we should be looking for at home?

Questions for You

  • Have you or any family members noticed difficulty hearing, especially in crowded or noisy environments?
  • Do you ever feel clumsy, unsteady on your feet, or notice unusual muscle weakness?
  • Looking back at family history, did any relatives have both vision loss and other neurological "quirks" that were never fully explained?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    [Genetic Causes and Genetic Diagnostic Testing of Inherited Optic Atrophies].

    Wissinger B

    Klinische Monatsblatter fur Augenheilkunde 2018; (235(11)):1235-1241 doi:10.1055/a-0759-2094.

    PMID: 30458563
  2. 2

    IT TAKES TWO TO TANGO: potential novel therapies for autosomal dominant optic atrophy.

    Sampige R, Seaborn LEA, Pluenneke M, et al.

    Frontiers in ophthalmology 2025; (5()):1688232 doi:10.3389/fopht.2025.1688232.

    PMID: 41268195
  3. 3

    Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.

    Ham M, Han J, Osann K, et al.

    Mitochondrion 2019; (46()):262-269 doi:10.1016/j.mito.2018.07.006.

    PMID: 30165240
  4. 4

    A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family.

    Ahmad KE, Davis RL, Sue CM

    Journal of neurology 2015; (262(10)):2323-8 doi:10.1007/s00415-015-7849-6.

    PMID: 26194196
  5. 5

    Characterisation of a novel OPA1 splice variant resulting in cryptic splice site activation and mitochondrial dysfunction.

    Harvey JP, Yu-Wai-Man P, Cheetham ME

    European journal of human genetics : EJHG 2022; (30(7)):848-855 doi:10.1038/s41431-022-01102-0.

    PMID: 35534703
  6. 6

    Autosomal dominant optic atrophy with OPA1 gene mutations accompanied by auditory neuropathy and other systemic complications in a Japanese cohort.

    Maeda-Katahira A, Nakamura N, Hayashi T, et al.

    Molecular vision 2019; (25()):559-573.

    PMID: 31673222
  7. 7

    Autosomal dominant optic atrophy plus due to the novel OPA1 variant c.1463G>C.

    Finsterer J, Laccone F

    Metabolic brain disease 2019; (34(4)):1023-1027 doi:10.1007/s11011-019-00425-0.

    PMID: 31152339
  8. 8

    Drosophila model to clarify the pathological significance of OPA1 in autosomal dominant optic atrophy.

    Nitta Y, Osaka J, Maki R, et al.

    eLife 2024; (12()).

    PMID: 39177028
  9. 9

    Increased steroidogenesis promotes early-onset and severe vision loss in females with OPA1 dominant optic atrophy.

    Sarzi E, Seveno M, Angebault C, et al.

    Human molecular genetics 2016; (25(12)):2539-2551 doi:10.1093/hmg/ddw117.

    PMID: 27260406
  10. 10

    Visual Function and Inner Retinal Structure in Relation to Birth Factors in Autosomal Dominant Optic Atrophy.

    Eckmann-Hansen C, Bek T, Sander B, Larsen M

    Investigative ophthalmology & visual science 2023; (64(10)):32 doi:10.1167/iovs.64.10.32.

    PMID: 37498569
  11. 11

    Molecular Impairment Mechanisms of Novel OPA1 Mutations Predicted by Molecular Modeling in Patients With Autosomal Dominant Optic Atrophy and Auditory Neuropathy Spectrum Disorder.

    Namba K, Mutai H, Takiguchi Y, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2016; (37(4)):394-402 doi:10.1097/MAO.0000000000000978.

    PMID: 26905822

This page explains ADOA genetics and subtypes for educational purposes. Consult a genetic counselor or neurologist to discuss your specific OPA1 mutation and personal symptom monitoring.

Stay up to date

Get notified when new research about Autosomal dominant optic atrophy, classic form is published.

No spam. Unsubscribe anytime.